<SEC-DOCUMENT>0001157523-19-001513.txt : 20190711
<SEC-HEADER>0001157523-19-001513.hdr.sgml : 20190711
<ACCEPTANCE-DATETIME>20190711161859
ACCESSION NUMBER:		0001157523-19-001513
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20190711
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20190711
DATE AS OF CHANGE:		20190711

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			COLGATE PALMOLIVE CO
		CENTRAL INDEX KEY:			0000021665
		STANDARD INDUSTRIAL CLASSIFICATION:	PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844]
		IRS NUMBER:				131815595
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-00644
		FILM NUMBER:		19951339

	BUSINESS ADDRESS:	
		STREET 1:		300 PARK AVE
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
		BUSINESS PHONE:		2123102000

	MAIL ADDRESS:	
		STREET 1:		300 PARK AVE
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a52012037.htm
<DESCRIPTION>COLGATE-PALMOLIVE COMPANY 8-K
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Business Wire
         Document created using EDGARfilings PROfile 6.0.0.0
         Copyright 1995 - 2019 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-weight: bold;">UNITED STATES</div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
    <div style="text-align: center; font-weight: bold;">Washington, D.C. 20549</div>
    <div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2.5px; width: 15%; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-weight: bold;">FORM 8-K</div>
    <div><br>
    </div>
    <div style="text-align: center; font-size: 14pt; font-weight: bold;">CURRENT REPORT</div>
    <div>&#160;</div>
    <div style="text-align: center; font-weight: bold;">Pursuant to Section 13 or 15(d) of the<br>
      Securities Exchange Act of 1934</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">Date of Report (Date of earliest event reported):</div>
    <div style="text-align: center; font-weight: bold;">July 11, 2019 (July 11, 2019)</div>
    <div><br>
    </div>
    <div style="text-align: center; font-size: 18pt; font-weight: bold;">COLGATE-PALMOLIVE COMPANY</div>
    <div>&#160;</div>
    <div style="text-align: center;">(Exact Name of Registrant as Specified in Charter)</div>
    <div style="font-size: 8pt;">&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z9edc0a8e241b4af588c3021179f1f5af">

        <tr>
          <td style="width: 33.33%; vertical-align: top;">
            <div style="text-align: center; font-weight: bold;">Delaware</div>
          </td>
          <td style="width: 34%; vertical-align: top;">
            <div style="text-align: center; font-weight: bold;">1-644</div>
          </td>
          <td style="width: 33.33%; vertical-align: top;">
            <div style="text-align: center; font-weight: bold;">13-1815595</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.33%; vertical-align: top;">
            <div style="text-align: center; font-size: 8pt;">(State or Other jurisdiction of<br>
              Incorporation)</div>
          </td>
          <td style="width: 34%; vertical-align: bottom;">
            <div style="text-align: center; font-size: 8pt;">(Commission<br>
              File Number)</div>
          </td>
          <td style="width: 33.33%; vertical-align: top;">
            <div style="text-align: center; font-size: 8pt;">(I.R.S. Employer<br>
              Identification No.)</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z823b04179fe34ceb890f2e2c3611a185">

        <tr>
          <td style="width: 100%; vertical-align: top;">
            <div style="text-align: center; font-weight: bold;">300 Park Avenue<br>
              New York, NY 10022</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top;">
            <div style="text-align: center; font-size: 8pt;">(Address of Principal Executive Offices) (Zip Code)</div>
          </td>
        </tr>

    </table>
    <div style="font-family: 'Times New Roman', serif; font-size: 3pt;">&#160;</div>
    <div>&#160;</div>
    <div style="text-align: center;">Registrant&#8217;s telephone number, including area code:<font style="font-weight: bold;">&#160; (212) 310-2000</font></div>
    <div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2.5px; width: 15%; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">Check the appropriate box below if the Form 8-K filing is
        intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<font style="font-style: italic;">see</font> General Instruction A.2. below):</div>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify;">&#9744;<font style="text-indent: 0px; font-size: 6pt;" id="TRGRRTFtoHTMLTab">&#160;&#160;&#160;&#160;</font>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
    <div>&#9744;<font style="text-indent: 0px; font-size: 6pt;" id="TRGRRTFtoHTMLTab">&#160;&#160;&#160;&#160;</font>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
    <div style="text-align: justify;">&#9744;<font style="text-indent: 0px; font-size: 6pt;" id="TRGRRTFtoHTMLTab">&#160;&#160;&#160;&#160;</font>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
    <div>&#9744;<font style="text-indent: 0px; font-size: 6pt;" id="TRGRRTFtoHTMLTab">&#160;&#160;&#160;&#160;</font>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
    <div>&#160;</div>
    <div>Securities registered pursuant to Securities 12(b) of the Act: <br>
    </div>
    <div> <br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z7ed49d1f446f4db8a04de2e95e47a165">

        <tr>
          <td style="width: 35%; vertical-align: bottom; border-top: #000000 4px double; border-bottom: #000000 2px solid;">
            <div style="text-align: center; font-weight: bold;">Title of each class</div>
          </td>
          <td style="width: 30%; vertical-align: bottom; border-top: #000000 4px double; border-bottom: #000000 2px solid;">
            <div style="text-align: center; font-weight: bold;">Trading Symbol(s)</div>
          </td>
          <td style="width: 35%; vertical-align: bottom; border-top: #000000 4px double; border-bottom: #000000 2px solid;">
            <div style="text-align: center; font-weight: bold;">Name of each exchange<br>
              on which registered</div>
          </td>
        </tr>
        <tr>
          <td style="width: 35%; vertical-align: middle; border-top: #000000 2px solid;">
            <div style="text-align: center;">Common Stock, $1.00 par value</div>
          </td>
          <td style="width: 30%; vertical-align: middle; border-top: #000000 2px solid;">
            <div style="text-align: center;">CL</div>
          </td>
          <td style="width: 35%; vertical-align: middle; border-top: #000000 2px solid;">
            <div style="text-align: center;">New York Stock Exchange</div>
          </td>
        </tr>
        <tr>
          <td style="width: 35%; vertical-align: middle;">
            <div style="text-align: center;">0.500% Notes due 2026</div>
          </td>
          <td style="width: 30%; vertical-align: middle;">
            <div style="text-align: center;">CL 26</div>
          </td>
          <td style="width: 35%; vertical-align: middle;">
            <div style="text-align: center;">New York Stock Exchange</div>
          </td>
        </tr>
        <tr>
          <td style="width: 35%; vertical-align: middle; border-bottom: #000000 4px double;">
            <div style="text-align: center;">1.375% Notes due 2034</div>
          </td>
          <td style="width: 30%; vertical-align: middle; border-bottom: #000000 4px double;">
            <div style="text-align: center;">CL 34</div>
          </td>
          <td style="width: 35%; vertical-align: middle; border-bottom: #000000 4px double;">
            <div style="text-align: center;">New York Stock Exchange</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div>Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2).</div>
    <div>&#160;</div>
    <div>Emerging growth company&#160; <font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font></div>
    <div>&#160;</div>
    <div>If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange
      Act.&#160; <font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font></div>
    <div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2.5px; width: 100%; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
    </div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z76ea4f07e2274f75a72a89761340413e">

            <tr>
              <td style="width: 72pt; vertical-align: top; align: right; font-weight: bold;">Item 8.01.</td>
              <td style="width: auto; vertical-align: top;">
                <div style="font-weight: bold;">Other Events.</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">On July 11, 2019, Colgate-Palmolive Company (&#8220;<u>Colgate</u>&#8221;) announced that Colgate and Filorga Initiatives (&#8220;Filorga&#8221;) entered into a Share Purchase Agreement, dated as of July 11, 2019 (the &#8220;<u>Share Purchase
        Agreement</u>&#8221;), pursuant to which Colgate has agreed to acquire Laboratoires Filorga Cosm&#233;tiques (the &#8220;<u>Company</u>,&#8221; and such transaction, the &#8220;<u>Transaction</u>&#8221;) for an equity purchase price of &#8364;1,495.5 million in cash.&#160; At the closing of
      the Transaction, Colgate will acquire the Company, including cash, debt and working capital it has accrued since January 1, 2019, and Colgate will pay Filorga an amount of interest on the purchase price calculated at an annual rate of 2% in respect
      of the period commencing January 1, 2019 and ending on the closing date of the Transaction.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">The consummation of the Transaction is subject only to the approval of the Austrian Federal Competition Authority, the French Competition Authority and the Federal Antimonopoly Service of the Russian Federation, as well
      as the absence of any governmental proceeding, order or law that would prohibit the consummation of the Transaction (together, the &#8220;<u>Closing Conditions</u>&#8221;).</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">The Share Purchase Agreement contains representations and warranties by each of Filorga and Colgate, which are subject to certain qualifications and exceptions.&#160; The Company has obtained representation and warranty
      insurance from a third party insurer, which will provide a limited amount of coverage for breaches of Filorga&#8217;s representations and warranties, subject to deductibles and certain other terms and conditions.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">Either party may terminate the Share Purchase Agreement if the Closing Conditions are not satisfied on or before December 31, 2019, provided, however, that each of Colgate and Filorga have a right to extend this date to
      March 31, 2020 without the consent of the other party.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">The Share Purchase Agreement also provides Colgate with certain rights to recover from Filorga for, among other things, breaches of certain fundamental representations and warranties of Filorga and with respect to
      certain claims or proceedings related to Filorga&#8217;s other businesses and that do not relate to the Company&#8217;s business.&#160; Filorga has also agreed to certain non-compete and employee non-solicitation obligations which will continue for a period of three
      years from closing, and Filorga and the Company (and/or certain of their affiliates) will provide transitional services to each other for a limited post-closing period.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">A copy of the press release issued by Colgate announcing the execution of the Share Purchase Agreement is attached hereto as <u>Exhibit 99.1</u> and is incorporated by reference into this Item 8.01.</div>
    <div>&#160;</div>
    <div style="text-indent: -72pt; margin-left: 72pt; font-style: italic; font-weight: bold;">Cautionary Note Regarding Forward-Looking Statements</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">This Current Report on Form 8-K may contain forward-looking statements (as that term is defined in the U.S. Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission (the &#8220;<u>SEC</u>&#8221;)
      in its rules, regulations and releases) that set forth, among other things, anticipated results based on management&#8217;s plans and assumptions and the timing of completion of the Transaction.&#160; Such statements may relate, for example, to the expected
      timing of the closing of the Transaction and the expected impact on 2019 earnings, among other matters.&#160; These statements are made on the basis of Colgate&#8217;s views and assumptions as of this time, and Colgate undertakes no obligation to update these
      statements whether as a result of new information, future events or otherwise, except as required by law or by the rules and regulations of the SEC.&#160; Moreover, Colgate does not, nor does any other person, assume responsibility for the accuracy and
      completeness of these statements.&#160; Colgate cautions investors that any such forward-looking statements are not guarantees of future performance and that actual events or results may differ materially from those statements.&#160; For more information about
      factors that could impact Colgate&#8217;s business and cause actual results to differ materially from forward-looking statements, investors should refer to Colgate&#8217;s filings with the SEC (including, but not limited to, the information set forth under the
      captions &#8220;Risk Factors&#8221; and &#8220;Cautionary Statement on Forward-Looking Statements&#8221; in Colgate&#8217;s Annual Report on Form 10-K for the year ended December 31, 2018, and subsequent Quarterly Reports on Form 10-Q).&#160; Copies of these filings may be obtained
      from Colgate&#8217;s website at http://www.colgatepalmolive.com.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc0f90b477fa14e86ab664daaacac16a2">

            <tr>
              <td style="width: 72pt; vertical-align: top; align: right; font-weight: bold;">Item 9.01.</td>
              <td style="width: auto; vertical-align: top;">
                <div style="font-weight: bold;">Financial Statements and Exhibits.</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div>&#160;</div>
    <div>(d) Exhibits</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zd54909c6712f4e54baeaa46ed5fffc6a">

        <tr>
          <td style="width: 10%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>
              <div style="font-size: 8pt; font-weight: bold;">Exhibit<br>
                Number</div>
            </div>
          </td>
          <td style="width: 2%; vertical-align: bottom; padding-bottom: 2px;">
            <div style="font-size: 8pt;">&#160;&#160;</div>
          </td>
          <td style="width: 88%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-size: 8pt; font-weight: bold;">Description</div>
          </td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: middle;">&#160;</td>
          <td style="width: 2%; vertical-align: middle;">&#160;</td>
          <td style="width: 88%; vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: top;">
            <div><a href="a52012037ex99_1.htm">99.1</a></div>
          </td>
          <td style="width: 2%; vertical-align: bottom;">
            <div>&#160;&#160;</div>
          </td>
          <td style="width: 88%; vertical-align: top;">
            <div><a href="a52012037ex99_1.htm">Press Release, dated July 11, 2019.</a></div>
          </td>
        </tr>

    </table>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; font-weight: bold;">SIGNATURE</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</div>
    <div>&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" border="0" id="za6c84daf811341c987b3284c5e835b98" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

          <tr>
            <td style="width: 50%;">
              <div>&#160;</div>
            </td>
            <td colspan="2" rowspan="1" style="width: 6%;">
              <div style="font-weight: bold;">COLGATE-PALMOLIVE COMPANY</div>
            </td>
            <td style="width: 10%;">
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%;">
              <div>&#160;</div>
            </td>
            <td style="width: 6%;">
              <div>&#160;</div>
            </td>
            <td style="width: 34%;">
              <div>&#160;</div>
            </td>
            <td style="width: 10%;">
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%;">
              <div>&#160;</div>
            </td>
            <td style="width: 6%;">
              <div>&#160;</div>
            </td>
            <td style="width: 34%;">
              <div>&#160;</div>
            </td>
            <td style="width: 10%;">
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%;">
              <div>&#160;</div>
            </td>
            <td style="width: 6%;">
              <div>&#160;</div>
            </td>
            <td style="width: 34%;">
              <div>&#160;</div>
            </td>
            <td style="width: 10%;">
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; padding-bottom: 2px;">
              <div>&#160;</div>
            </td>
            <td style="width: 6%; padding-bottom: 2px;">
              <div>By:</div>
            </td>
            <td style="width: 34%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>/s/ Jennifer M. Daniels</div>
            </td>
            <td style="width: 10%; padding-bottom: 2px;">
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%;">
              <div>&#160;</div>
            </td>
            <td style="width: 6%;">
              <div>Name:</div>
            </td>
            <td style="width: 34%;">
              <div>Jennifer M. Daniels</div>
            </td>
            <td style="width: 10%;">
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%;">
              <div>&#160;</div>
            </td>
            <td style="width: 6%;">
              <div>Title:</div>
            </td>
            <td style="width: 34%;">
              <div>Chief Legal Officer and Secretary</div>
            </td>
            <td style="width: 10%;">
              <div>&#160;</div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div> <br>
  </div>
  <div> Date:&#160; July 11, 2019<br>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a52012037ex99_1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Business Wire
         Document created using EDGARfilings PROfile 6.0.0.0
         Copyright 1995 - 2019 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 99.1</font><br>
  </div>
  <div><font style="font-weight: bold;"> <br>
    </font></div>
  <div>
    <div class="bw-release">
      <h1 style="text-align: center; list-style-position:inside;FONT-SIZE: 14pt;"> <font style="font-size: 11pt;"><b>Colgate Announces Agreement to Acquire Laboratoires Filorga Cosm&#233;tiques Skin Care Business</b></font> </h1>
      <div class="bw-release-body">
        <div class="bw-release-table-js bw-release-story">
          <p>NEW YORK--(BUSINESS WIRE)--July 11, 2019--As part of its strategy to focus on its higher-margin oral care, personal care and pet nutrition businesses, and expanding its portfolio in premium skin care, Colgate-Palmolive Company (NYSE:CL) today
            announced that it has agreed to acquire the Laboratoires Filorga Cosm&#233;tiques (Filorga) Skin Care Business for an equity purchase price of &#8364;1,495.5 million (approximately US$1,690 million).<b> </b> </p>
          <p> Filorga is a premium anti-aging skin care brand focused primarily on facial care. Originally founded in France in 1978, the brand is now sold in over 60 countries with its largest markets being France, Italy, Spain and Greater China. The
            Filorga brand leverages a multi-channel distribution strategy across pharmacy, online, specialty stores and travel retail. </p>
          <p> Noel Wallace, Colgate&#8217;s President and CEO commented, &#8220;Filorga is a strong, premium-priced brand with distinctive positioning that fits well within our long-term personal care growth strategy. We are excited that this acquisition will add a
            high-growth, profitable, global skin care asset to the Colgate portfolio with the opportunity to drive continued growth through expanded distribution and awareness. This acquisition also provides Colgate entry into the fast-growing and sizeable
            travel retail channel, particularly in Asia.&#8221; </p>
          <div> </div>
          <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" id="DSPFPageBreakArea">
            <div style="PAGE-BREAK-AFTER: always" id="DSPFPageBreak">
              <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
          </div>
          <p> The transaction will be financed with a combination of debt and cash and is currently expected to close in the third quarter of 2019. The acquisition is conditioned upon receipt of regulatory approvals in certain countries. </p>
          <p> The transaction is expected to have no impact on diluted earnings per share in 2019. </p>
          <p> Wachtell, Lipton, Rosen &amp; Katz and CMS Francis Lefebvre Avocats acted as legal advisors and Citi acted as financial advisor to Colgate-Palmolive on the transaction. Bredin Prat acted as legal advisor and Goldman Sachs and BNP Paribas
            acted as financial advisors to Filorga Initiatives on the transaction. </p>
          <p style="text-align: center; list-style-position:inside;"> *** </p>
          <p> About Colgate-Palmolive: Colgate-Palmolive is a leading global consumer products company, tightly focused on Oral Care, Personal Care, Home Care and Pet Nutrition. Colgate sells its products in over 200 countries and territories around the
            world under such internationally recognized brand names as Colgate, Palmolive, elmex, Tom's of Maine, Sorriso, Speed Stick, Lady Speed Stick, Softsoap, Irish Spring, Protex, Sanex, Elta MD, PCA Skin, Ajax, Axion, Fabuloso, Soupline and
            Suavitel, as well as Hill&#8217;s Science Diet and Hill&#8217;s Prescription Diet. For more information about Colgate&#8217;s global business, visit the Company&#8217;s website at http://www.colgatepalmolive.com. To learn more about the Colgate Bright Smiles, Bright
            Futures&#174; oral health education program, please visit http://www.colgatebsbf.com. CL-C </p>
          <div> </div>
          <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" id="DSPFPageBreakArea">
            <div style="PAGE-BREAK-AFTER: always" id="DSPFPageBreak">
              <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
          </div>
          <p> <u>Cautionary Statement on Forward-Looking Statements</u> </p>
          <p> This press release may contain forward-looking statements (as that term is defined in the U.S. Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission (SEC) in its rules, regulations and releases) that
            set forth, among other things, anticipated results based on management's plans and assumptions and the timing of completion of the transaction. Such statements may relate, for example, to the expected timing of the closing of the transaction
            and the expected impact on 2019 earnings, among other matters. These statements are made on the basis of the Company&#8217;s views and assumptions as of this time and the Company undertakes no obligation to update these statements whether as a result
            of new information, future events or otherwise, except as required by law or by the rules and regulations of the SEC. Moreover, the Company does not, nor does any other person, assume responsibility for the accuracy and completeness of these
            statements. The Company cautions investors that any such forward-looking statements are not guarantees of future performance and that actual events or results may differ materially from those statements. For more information about factors that
            could impact the Company's business and cause actual results to differ materially from forward-looking statements, investors should refer to the Company's filings with the SEC (including, but not limited to, the information set forth under the
            captions &#8220;Risk Factors&#8221; and &#8220;Cautionary Statement on Forward-Looking Statements&#8221; in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2018 and subsequent Quarterly Reports on Form 10-Q). Copies of these filings may be
            obtained from the Company's website at http://www.colgatepalmolive.com. </p>
        </div>
        <div class="bw-release-contact">
          <h2 style="font-size: 11pt;">Contacts</h2>
          <p> John Faucher 212-310-3653 <br>
            Hope Spiller 212-310-2291</p>
        </div>
      </div>
    </div>
    <font style="font-weight: bold;"> </font></div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
